Schulich school of Medicine and Dentistry logo Oncology Schulich School of Medicine & Dentistry

Education - Postgraduate - Fellowship Program

Postgraduate Fellowship Program

Radiation Oncology Fellowship

Interested Applicants

One fellowship position (1)  is available for the Academic year.   Information about the fellowship and how to apply will posted in the summer of 2019 for July 1, 2020.

 

 

 

Medical Oncology Fellowship

Interested Applicants

One fellowship position (1)  is available for the Academic year July 1, 2019 to June 30, 2020 at the PGY-6 salary level through PARO.  Applications are invited from physicians who hold a Fellowship of the Royal College of Physicians and Surgeons of Canada (RCPSC) or the equivalent training.  Candidates will have completed a training program in one of the oncology subspecialties, be licensed with, or be eligible for an educational license from the College of Physicians and Surgeons of Ontario (CPSO).

Application Process and Requirements

Requirements:

  • The applicant must have a specialist degree.
  • If the language of instruction at your medical school was other than English, you must have written your IELTS test and obtained a Band score of 8 or higher to be eligible to apply. No exceptions.

Deadline for Submission:

Send complete package with the following by no later than
September 1, 2018 (for possible Fellowship start date of July 2019)

What you need to send:

Interested applicants should forward a covering letter outlining their proposed area of interest, indicating the specific fellowship position interested in. Also include:

  • An up-to-date CV
  • Completed Application Form
  • 3 (three)letters of reference (Must use referee form)
  • This must also be submitted directly by the referee. Please note:  We will NOT accept referee forms submitted by the applicant.
  • Copies of your medical degree, Oncology certification, and a coyof your immigration status (ie. Passport, Visa, etc.)
  • Applications are accepted between July/August
  • English Language Testing:

Contact:  Ms. Cassandra Ratelle
Administrator Fellowship Program
Department of Oncology
Schulich School of Medicine & Dentistry
Western University
c/o London Regional Cancer Program
800 Commissioners Road East
London, Ontario, N6A 5W9
Email: cassandra.ratelle@lhsc.on.ca

Background

Western University is at the forefront in the emerging field of Personalized Medicine. Understanding inter-individual variability in drug metabolism and tolerance is no where more important than in the practice of oncology. Investigators at the London Regional Cancer Program (LRCP) work in collaborating with the Departments of Clinical Pharmacology and Diagnostic Imaging on novel approaches to individualize therapy in cancer patients.

The LRCP serves as the regional referral service for tertiary oncology care for Southwestern Ontario, a cachement area of over 1.5 million people. The Clinical Research Unit at LRCP has established expertise in conducting a wide range of clinical trials, including “in-house”, industry and co-operative group sponsored studies. The LRCP has a strong relationship to basic science researchers situated in close proximity at the Victoria Cancer Research Laboratories. There exist translational research teams of clinicians and scientists in the breast, prostate and gynecologic disease site teams. We have strong linkages to the Princess Margaret Hospital Phase 2 Consortium, Ontario Institute for Cancer Research (OICR) and the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). Facilities exist both at the Victoria and University Campuses of London Health Sciences Center to support translational research of the highest quality.

Objectives

To allow the fellow to:

  • Conduct one or more translational research projects in the field of personalized medicine under the guidance of experienced investigators from the Departments of Clinical Pharmacology and Oncology.
  • Learn advanced elements in clinical pharmacology relevant to the practice of oncology.
  • Gain experience in the conduct and implementation of prospective clinical research in cancer patients.

Mentorship

Oncology:

  • Dr. Stephen Welch (Fellowship Program Director): Medical Oncologist with significant involvement and experience in IND trials and interest in Personalized Medicine with ongoing collaborative research underway with the Department of Clinical Pharmacology.
  • Dr. Eric Winquist

Clinical Pharmacology:

  • Dr. Richard Kim: General Internist / Clinical Pharmacologist with vast experience in pharmacogenomics and drug transporters. His research interest is that of understanding the molecular basis of inter-individual differences in drug disposition and the application of such finding to the emerging field of Personalized Medicine.
  • Dr. George Dresser

Time Commitments

  • 40% of time will be devoted to clinical experience and direct patient interaction
    This will include oncology clinics at LRCP, participation in clinical pharmacology consult service and opportunities for on-call service with oncology and clinical research programs.
  • 40% of the time will be devoted to conceptualizing, conduct and implementation of specific research projects
    The project(s) will be geared toward personalized medicine in oncology. Projects will be feasible to complete within a short time period of the fellowship. Although the focus is on clinical research projects, opportunities for experience with small projects, in the basic science laboratories (Experimental Oncology and / or Clinical Pharmacology) will be offered.
  • 20% of the time will be devoted to formal and informal course work in clinical pharmacology centered around the theme of personalized medicine
  • Seminars and courses offered through:
    Division of Clinical Pharmacology
    CIHR Strategic Training Program in Cancer Research and Technology Transfer
  • Attendance at the following regular meetings will be considered mandatory:
    • Dr. Kim's Lab Meeting: weekly meeting where work from trainees / post-docs associated with Dr. Kim’s team presented. Fellow will be expected to report on progress of his / her own projects as fellowship progresses.
    • IND Rounds: monthly meeting of clinicians and basic scientists at LRCP to discuss relevant molecular biology and new drug targets. Fellow will be expected to participate in discussion and present on occasion.
    • Grand Rounds: weekly for both the Departments of Oncology and Division of Clinical Pharmacology
    • Clinical Pharmacology Academic Half-Day
    • CIHR Strategic Training Program in Cancer Research and Technology Tranfer Seminar Series (monthly)

  • It is expected that a one or two year commitment will be made by the fellow to allow completion of the fellowship objectives.  The fellow will be expected to take part in limited amount of after hours and weekend coverage for the appropriate Oncology division which will be negotiated at the start of the fellowship.

Recruitment

Fellows will be recruited from the Oncology Training Program at the LRCP and from other oncology training programs (Canadian and International). The existence of the Personalized Medicine in Oncology Fellowship at Western University will be communicated to other training programs at through advertisement at national and international oncology meetings / conferences. Given the focus on pharmacology and personalized medicine, candidates are most likely to have a medical oncology background, however, interested and qualified individuals from Radiation, Surgical or Gynecologic Oncology training programs are welcome.

Salary

Salary for the fellow will be at the level of a PGY-6 resident as per the Professional Association of Internes and Residents of Ontario (PARO) guidelines. Funding will also be made available for the fellow to attend up to 2 national / international meetings per year where his / her work is to be presented. Limited funding will also be made available to offset costs of research conducted (supplies, personnel, etc.)

Seminar Series

Newcomers to Canada and Help with Arrival

For all information to help you transition to Canada and with your arrival, see related information